Frost & Sullivan awards Nanjing Nuoyuan Medical Devices Co., Ltd. the 'China Functional Endoscopy Innovation Award'

Frost & Sullivan awarded Nanjing Nuoyuan Medical Devices Co., Ltd.

‘China Functional Endoscope Innovation Award’

Mr. Wang Chenhui presented the award to Cai Huiming, Founder of Nuoyuan Medical

Nanjing Nuoyuan Medical Devices Co., Ltd. (hereinafter referred to as Nuoyuan Medical) was established in 2011 and is a national high-tech enterprise integrating the research, development, production and sales of high-end medical devices and innovative targeted probes. Nuoyuan Medical is committed to meeting the clinical needs of precise tumor diagnosis and treatment, mastering core technologies in multiple aspects such as fluorescence endoscope design and manufacturing technology, endoscope imaging technology and platform integration technology, achieving efficient transformation and clinical application of technical achievements, developing functional endoscope products at an internationally advanced level, and its research team has innovatively explored ultra-high detection sensitivity of fluorescent tracers, especially cutting-edge technologies such as quantitative analysis function and tumor boundary sharpening, breaking through technical barriers such as real-time intraoperative detection of sub-millimeter-level micro-lesions and precise marking of tumor digital boundaries, providing a new solution for clinical formulation of more accurate surgical plans and reduction of damage to surrounding healthy tissues. At present, its surgical fluorescence imaging system and 4K endoscope fluorescence imaging system have been successfully launched, completing a multi-dimensional functional leap. At the same time, the composite product '4K 3D Endoscope Fluorescence Imaging System', integrating three functions of 3D, 4K and fluorescence, has been approved to enter the innovative medical device registration procedure.

Nuoyuan Medical has established an innovative model of 'simultaneous development of drugs and medical devices', utilizing its deep accumulation in drug research and development to develop the broad-spectrum fluorescent probe indocyanine green suitable for imaging systems; at the same time, using AI assistance and CADD technology, it has developed targeted fluorescent probes for multiple typical tumor receptors, among which the new generation of targeted 'Peme' fluorescent tracer is expected to bring important improvements in terms of improving the accuracy and effectiveness of tumor surgery, and improving the prognosis and quality of life of patients. Compared with similar foreign fluorescent tracers, 'Peme' fluorescent tracer has high specificity and can significantly reduce the false positive rate. At present, 'Peme' fluorescent tracer has obtained invention patent authorization in countries and regions such as China, the United States, Europe, and Japan. At the same time, Nuoyuan Medical further deepens its technical advantages in the field of molecular fluorescence, and the ongoing research on molecular fluorescence composite navigation technology deeply integrates molecular fluorescence and Raman spectroscopy, achieving a leap from tumor pathological boundaries to molecular gene boundaries through self-developed algorithms. In addition, Nuoyuan Medical continues to explore minimally invasive precision treatment solutions, integrating exclusive ablation simulation technology, conformal ablation technology and carbonization regulation technology to effectively solve clinical problems of tumor microwave treatment and achieve precise ablation throughout the preoperative, intraoperative and postoperative processes.

Since its establishment in 2011, Nuoyuan Medical has undertaken more than ten national and provincial key research projects such as the 'National 13th Five-Year Plan Key Research and Development Program', 'National Major Scientific Instrument Development Project', 'National Ministry of Industry and Information Technology Artificial Intelligence Medical Device Innovation Task Announcement', and 'Jiangsu Province Key Core Technology Research Project'. At the same time, Nuoyuan Medical actively expands into the international market, and in terms of patent layout, it has authorized 77 domestic and foreign invention patents, achieving patent protection for the whole machine and core components. At the same time, Nuoyuan Medical has carried out strategic cooperation with international leading companies such as B&R in Germany to promote the registration of products in China, the United States and Europe.